Pregnancy Related Clinical Trial
— PRENAYOGAOfficial title:
PRENAYOGA: Exploratory Feasibility Study of Bi-weekly Pregnancy Yoga-based Sessions for Ethnic Minority Women
Verified date | March 2023 |
Source | King's College London |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Depression and anxiety are the most prevalent psychiatric disorders in the perinatal period. A recent report found that nearly 50% of new mothers in London (where 40% of the population is of ethnic minority background) display symptoms of postnatal depression (PND). A 2022 report by the London School of Economics (LSE) found that treating maternal mental illness could save the National Health Service (NHS) £52 million over 10 years; in 2014, the LSE calculated that two-thirds of that cost is linked to adverse child development. Prenatal depression results in adverse outcomes for the mother and infant, which are also linked to the impact of postnatal depression on the emotional relationship and attachment between the mother and the child. The major risk for developing depression postnatally is a history of depression, either in the lifetime or during pregnancy. Several studies highlight that antenatal depression rates are higher in ethnic minority women. However, the percentage of ethnically diverse women in most studies on perinatal depression is negligible. Additionally, ethnic minority women are less represented in perinatal mental health therapeutic settings. Preliminary evidence indicates prenatal yoga reduces anxiety and depression and improves mother-foetal attachment. Ethnic minorities support mind-body interventions such as yoga and may be more likely to engage in community-based activities than traditional antenatal classes. An 8-week feasibility study will assess the feasibility and acceptability of a yoga-based intervention for ethnic minority women in London.
Status | Completed |
Enrollment | 15 |
Est. completion date | June 17, 2023 |
Est. primary completion date | June 3, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Gestational age: week 20 of gestation or over, at the first session. - Over 18 years of age. - Basic understanding of English. - Able to travel to the sessions. - Belonging to an ethnic minority group (self-identified) other than White. Exclusion Criteria: - Physical or mental health diagnosis that would prevent them from attending yoga sessions, as per their healthcare professional's advice (self-reported). |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Maurice Wohl Clinical Neuroscience Institute, 5 Cutcombe Rd, Brixton, London SE5 9RT | London |
Lead Sponsor | Collaborator |
---|---|
King's College London |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To assess the acceptability of the intervention | Total score of the Acceptability of Intervention Measure (AIM). The Acceptability of Intervention Measure (AIM) has a scale range of 1-5, with higher scores indicating greater acceptability. | End of intervention (week 8). | |
Secondary | To assess reasons for perceived acceptability of the intervention | Focus groups | End of intervention (week 8). | |
Secondary | To assess uptake/reach of the intervention | Number of eligible women that sign up to the intervention | End of intervention (week 8). | |
Secondary | To assess the appropriateness of the intervention | Total score of the Intervention Appropriateness Measure (IAM). The Intervention Appropriateness Measure (IAM) has a scale range of 1-5, with higher scores indicating greater appropriateness of the intervention. | End of intervention (week 8). | |
Secondary | To assess the feasibility of the intervention | Total score of the Feasibility of Intervention Measure (FIM). FIM has a scale range of 1-5, higher scores indicate greater feasibility of the intervention, assessing the practicality and potential for success of an intervention in a particular setting or population based on factors such as ease of implementation, cost-effectiveness, and stakeholder acceptability. | End of intervention (week 8). | |
Secondary | To assess intervention adherence and attrition rates | Data on the overall adherence to the intervention, number of drops-outs each week. | End of intervention (week 8). | |
Secondary | To assess the effects of quality of life | EQ5D-5L (quality of life measure). The EQ5D-5L is a quality of life measure that can be presented as EQ VAS and EQ-5D-5L index value. | Start (baseline) and end of intervention (week 8). | |
Secondary | To assess factors affecting the sustainability and scalability of the intervention | Focus groups | End of intervention (week 8). | |
Secondary | To assess the effectiveness of group prenatal yoga to increase mother-foetal attachment | Exploratory investigation of the Maternal Foetal Attachment Scale. The Maternal Foetal Attachment Scale has 24 items. The items are scored on a five-point scale (1-5) with a total score ranging from 24 to 120, with higher scores indicating greater maternal-foetal attachment. | Start (baseline) and end of intervention (week 8). | |
Secondary | To assess the effectiveness of group prenatal yoga to increase mother-foetal attachment | Exploratory investigation of the Maternal Antenatal Attachment Scale. The Maternal Antenatal Attachment Scale has a scale range of 1-5 with a total score ranging from 19-95, with higher scores indicating greater maternal antenatal attachment. | Start (baseline) and end of intervention (week 8). | |
Secondary | To assess whether yoga improves further aspects of mental health | The Edinburgh Postnatal Depression Scale (EPDS). The Edinburgh Postnatal Depression Scale (EPDS) has a range of 0-3, with a scale total range of 0-30, where higher scores indicate greater depressive symptoms. | Start (baseline) and end of intervention (week 8). | |
Secondary | To assess whether yoga improves further aspects of mental health | Beck Depression Inventory (BDI). The Beck Depression Inventory (BDI) has a scale range of 0-63, with higher scores indicating greater depressive symptoms. Each answer is scored on a scale value of 0-3. | Start (baseline) and end of intervention (week 8). | |
Secondary | To assess whether yoga improves further aspects of mental health | State and Train Anxiety Inventory (STAI). The State and Trait Anxiety Inventory (STAI) is rated on a 4-point Likert scale and has a total scale range of 20-80, with higher scores indicating greater anxiety symptoms. | Start (baseline) and end of intervention (week 8). | |
Secondary | To assess whether yoga improves further aspects of mental health | Perceived Stress Scale (PSS). The PSS questionnaire typically contains 10 questions, and respondents rate their feelings and thoughts over the past month on a 5-point scale. The Perceived Stress Scale (PSS) has a scale range of 0-40, where higher scores indicate greater perceived stress. | Start (baseline) and end of intervention (week 8). | |
Secondary | To ascertain whether yoga affects mother-infant bond (postpartum) | Maternal Attachment Inventory (MAI). The Maternal Attachment Inventory (MAI) has a scale range of 22-88, with higher scores indicating greater maternal attachment. | Start (baseline) and end of intervention (week 8). | |
Secondary | To ascertain whether yoga improves social support and efficacy | Multidimensional Scale of Perceived Social Support (MSPSS). The Multidimensional Scale of Perceived Social Support (MSPSS) has a total scale range of 12-84 or subscale ranges of 3-7, with higher scores indicating greater perceived social support. | Start (baseline) and end of intervention (week 8). | |
Secondary | To ascertain whether yoga improves social support and efficacy | The Short General Self-Efficacy Scale (GSE-6). The Short General Self-Efficacy Scale (GSE-6) has a scale range of 6-30, with higher scores indicating greater general self-efficacy. | Start (baseline) and end of intervention (week 8). | |
Secondary | To identify how the yoga sessions affect the lived experience of ethnic minority pregnant women | Focus groups | End of intervention (week 8). | |
Secondary | To identify how the yoga sessions are perceived by the yoga teachers | Interviews | End of intervention (week 8). | |
Secondary | To assess the effectiveness of group prenatal yoga to increase mother-foetal attachment | Changes in scores of the Prenatal Attachment Inventory. The Prenatal Attachment Inventory has 21 items and is a scale ranging from 21-84, with higher scores indicating greater prenatal attachment.
items |
Start (baseline) and end of intervention (week 8). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Recruiting |
NCT04278651 -
Early Antenatal Support for Iron Deficiency Anemia
|
Phase 4 | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT06258902 -
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
|
||
Completed |
NCT05487196 -
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia
|
Phase 2 | |
Completed |
NCT03750968 -
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
|
Phase 2 | |
Enrolling by invitation |
NCT06127277 -
Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care
|
N/A | |
Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069869 -
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069856 -
Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Not yet recruiting |
NCT06079918 -
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
|
Phase 3 |